Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$3.6 - $5.88 $27,720 - $45,276
-7,700 Reduced 8.56%
82,300 $317,000
Q3 2022

Nov 09, 2022

BUY
$7.7 - $13.31 $20,790 - $35,937
2,700 Added 3.09%
90,000 $697,000
Q2 2022

Aug 09, 2022

BUY
$6.72 - $16.07 $88,032 - $210,517
13,100 Added 17.65%
87,300 $781,000
Q1 2022

May 09, 2022

BUY
$11.88 - $23.4 $64,152 - $126,359
5,400 Added 7.85%
74,200 $1.13 Million
Q3 2021

Nov 08, 2021

BUY
$27.67 - $45.04 $1.22 Million - $1.98 Million
44,000 Added 177.42%
68,800 $2.38 Million
Q2 2021

Aug 06, 2021

BUY
$28.75 - $56.92 $713,000 - $1.41 Million
24,800 New
24,800 $813,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $132M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.